Market players such as Thermo Fisher Scientific, Inc., QIAGEN N.V. (NASDAQ:QGEN), and ARKRAY, Inc. have established new manufacturing facilities and R&D plants in China, in order to take advantage of the high growth opportunities in the country. Qiagen NV (NASDAQ:QGEN) stock opened at $22.07 in last session, and closed at $22.01, while the day range of QGEN stock is $21.95 – $22.36. The stock showed a negative weekly performance of -0.05%.
In July 2013, the U.S. Supreme Court issued an important decision for the biotechnology industry in Association for Molecular Pathology v. Myriad Genetics Inc. (NASDAQ:MYGN). In its decision, the Court found that naturally occurring DNA sequences were not eligible to be patented in the United States under 35 U.S.C. § 101. Myriad Genetics, Inc. (NASDAQ:MYGN) stock opened at $37.44, in last session and closed at $37.40, by losing -0.11%. The 52 week range of MYGN is $20.02 – $39.15. Company’s market capitalization is $2.73billion.
“They are now becoming members in full standing of the C-suite and are in a position to drive business growth forward,” says Forrester Research, Inc. (NASDAQ:FORR)’s VP Sheryl Pattek, the firm’s principal analyst serving CMOs. Forrester Research, Inc. (NASDAQ:FORR) stock advanced 2.09% and finished the last session at $37.70. The EPS of the stock remained 0.61. Company’s market capitalization is $744.69million.
TheStreet cut shares of Bioanalytical System Inc (NASDAQ:BASI) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Bioanalytical Systems, Inc. (NASDAQ:BASI) stock opened the session at $2.75, and closed the session at $2.79. The 52 week range of the BASI stock remained $1.25 – $3.80 and the day range was $2.74 – $2.80.